6 reasons why Magellan Financial Group Ltd shares are soaring

Magellan Financial Group Ltd (ASX:MFG) shares continue to soar higher.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share price of Magellan Financial Group Ltd (ASX: MFG) soared to a record high of $26.15 this morning as investors wake up to its potential to become a major story in the history of Australian financial services.

This is a business I have repeatedly recommended to investors over the past two years and not for nothing either, below I have six reasons it retains a bright future.

Retail distribution – Led by the well-connected Frank Casarotti, Magellan has been able to crank retail FUM flows like clockwork over many years. It benefits from a widening distribution reach and the gradual shift to international equities as Australia's superannuation pool only keeps growing.

Institutional business development – Success in this area is dependent on a strong sales team, impressive management team and consistent long-term track record of beating the benchmark for relevant investment funds.

Most institutions and their consultants instinctively look to a five-year past performance record (among other time periods) versus a benchmark and on this basis Magellan beats most of its competitors. This alongside the fact it has created a growth sweet spot of strong leaders (Hamish Douglass) and sales teams means it is something of a sales machine.

Co-founder led – Magellan is led by its founders which brings all the benefits of a business focused on long-term underlying performance.

Fund managers and financial services business are often mired by staff focusing on their own short-term interests, rather than those of the business. Not at Magellan, which employs less staff than most, but likely rewards them more and therefore can retain and grow its best talent. Evidence of this is an astonishingly low cost to income ration of 20.6%.

Investment performance – This has been strong and is in part a product of the business's approach on long-term returns focusing on a global blue-chip strategy that is so popular with institutions and consultants like Mercers and Tower Watson.

Startup – Magellan now manages around $40 billion in FUM, while this may be considered a large amount in Australia, in global terms it's still very small as a global fund manager. The firm still only employs around 100 staff and Magellan is arguably still a startup (though likely not of the T-shirt wearing variety), which means it still has a huge growth horizon ahead.

US dollar exposure – The company's global funds are denominated in US dollars, which means revenues as a percentage of FUM rise and fall roughly in alignment with US dollar strength. In addition its cost base is almost exclusively in Australian dollars largely via staff wages, so it's a beneficiary of the Aussie dollar's fall.

The only word of caution I would exercise over this business is that the valuation is now getting high and it remains more leveraged than most to falls in equity markets, although on the flipside it's a likely big beneficiary of a strong 2016 for US equity markets. In other words it probably has a higher beta than most when measured against movements in the wider equity markets.

In my opinion however the overall outlook, management control, and startup nature of the business mean it remains an attractive buy.

Motley Fool contributor Tom Richardson owns shares of Magellan Financial Group. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »